Clinical Trial Services

Feb 13, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
A $800-million acquisition of MPI Research expands Charles River's offerings for early-stage contract research.
Jan 26, 2018
By Pharmaceutical Technology Editors
The contract development and manufacturing organization has invested £30-million (US$42 million) at its Dundalk, Ireland site to offer expanded clinical trial services.
Nov 03, 2017
By Pharmaceutical Technology Editors
The Human Vaccines Project has created the Universal Influenza Vaccine Initiative, a research program that will aim to understand the human immune system’s role in the development of universal influenza vaccines.
Nov 02, 2017
By Pharmaceutical Technology Editors
Capsugel announced on Oct. 31, 2017 that it expanded clinical trial capabilities, as well as increased development and manufacturing capabilities for specialized drug products using liquid-filled hard capsule technology, at its Edinburgh facility in Scotland.
Oct 20, 2017
By Pharmaceutical Technology Editors
The company has announced that it has acquired a new bioanalysis and biomarkers services facility in Laval, Montreal, Canada to support preclinical and clinical programs.
Oct 06, 2017
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Cytel, a biometrics CRO and clinical trial software provider, announced that it will be adding a new location for clinical development in Basel, Switzerland.
Oct 03, 2017
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
PCI Pharma Services, a pharmaceutical outsourcing services provider, will acquire Millmount Healthcare, a pharmaceutical and healthcare contract packaging services provider, to expand its European services.
May 15, 2017
Pharmaceutical Technology
The existing, obsolete highpurity water generation system and water-forinjection generation system were replaced with new, reliable technologies.
Apr 06, 2017
FDA is in the center of the debate over developing and pricing new cancer therapies.
Dec 14, 2016
By Pharmaceutical Technology Editors
BMS changes its US geographic footprint with R&D investments and closures.
native1_300x100
lorem ipsum